CS c.1394C>T ;(p.S465L)

Variant ID: 12-56666875-G-A

NM_004077.2(CS):c.1394C>T;(p.S465L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy.

The Journal Of Antimicrobial Chemotherapy
Blanch-Lombarte, Oscar O; Santos, José R JR; Peña, Ruth R; Jiménez-Moyano, Esther E; Clotet, Bonaventura B; Paredes, Roger R; Prado, Julia G JG
Publication Date: 2020-09-01

Variant appearance in text: CS: S465L
PubMed Link: 32556165
Variant Present in the following documents:
  • Main text
  • dkaa228.pdf
View BVdb publication page



Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.

Circulation. Cardiovascular Genetics
Hopkins, Paul N PN; Defesche, Joep J; Fouchier, Sigrid W SW; Bruckert, Eric E; Luc, Gérald G; Cariou, Bertrand B; Sjouke, Barbara B; Leren, Trond P TP; Harada-Shiba, Mariko M; Mabuchi, Hiroshi H; Rabès, Jean-Pierre JP; Carrié, Alain A; van Heyningen, Charles C; Carreau, Valérie V; Farnier, Michel M; Teoh, Yee P YP; Bourbon, Mafalda M; Kawashiri, Masa-Aki MA; Nohara, Atsushi A; Soran, Handrean H; Marais, A David AD; Tada, Hayato H; Abifadel, Marianne M; Boileau, Catherine C; Chanu, Bernard B; Katsuda, Shoji S; Kishimoto, Ichiro I; Lambert, Gilles G; Makino, Hisashi H; Miyamoto, Yoshihiro Y; Pichelin, Matthieu M; Yagi, Kunimasa K; Yamagishi, Masakazu M; Zair, Yassine Y; Mellis, Scott S; Yancopoulos, George D GD; Stahl, Neil N; Mendoza, Johanna J; Du, Yunling Y; Hamon, Sara S; Krempf, Michel M; Swergold, Gary D GD
Publication Date: 2015-12

Variant appearance in text: CS: Ser465Leu
PubMed Link: 26374825
Variant Present in the following documents:
  • hcg-8-823-s003.pdf
View BVdb publication page